COLLINS MORTON 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 14, 2018
Insider Transaction Report
Form 4
COLLINS MORTON
Director
Transactions
- Award
Restricted Stock Unit
2018-05-11+8,170→ 8,170 total→ Common Stock (8,170 underlying) - Exercise/Conversion
Restricted Stock Unit
2018-05-12−7,669→ 0 total→ Common Stock (7,669 underlying) - Exercise/Conversion
Common Stock
2018-05-12+7,669→ 159,960 total - Award
Common Stock Option
2018-05-11+12,500→ 12,500 totalExercise: $4.56Exp: 2028-05-11→ Common Stock (12,500 underlying)
Holdings
- 50,000(indirect: By IRA)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
- 6,650(indirect: By Spouse)
Common Stock
- 6,450(indirect: By Spouse)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
- 4,500(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018.
- [F2]Options to vest 100% on May 11, 2019.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019.